596 related articles for article (PubMed ID: 19237016)
1. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.
Chen C; Xu S; Wang WX; Ding YM; Yu KH; Wang B; Chen XY
Arch Med Res; 2009 Feb; 40(2):79-88. PubMed ID: 19237016
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
Celiński K; Madro A; Prozorow-Król B; Korolczuk A; Cichoz-Lach H; Słomka M; Korobowicz E
Med Sci Monit; 2009 Jan; 15(1):BR21-9. PubMed ID: 19114961
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis.
Liu HB; Cui NQ; Wang Q; Li DH; Xue XP
Pancreas; 2008 Apr; 36(3):e10-5. PubMed ID: 18362832
[TBL] [Abstract][Full Text] [Related]
5. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Cuzzocrea S
Immunology; 2006 Aug; 118(4):559-70. PubMed ID: 16764691
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis.
Luan ZG; Zhang XJ; Yin XH; Ma XC; Zhang H; Zhang C; Guo RX
Immunobiology; 2013 Oct; 218(10):1261-70. PubMed ID: 23706497
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury.
Chen P; Huang L; Sun Y; Yuan Y
Cytokine; 2011 Jun; 54(3):305-14. PubMed ID: 21419645
[TBL] [Abstract][Full Text] [Related]
8. Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis.
Rau BM; Krüger CM; Hasel C; Oliveira V; Rubie C; Beger HG; Schilling MK
Pancreas; 2006 Aug; 33(2):174-83. PubMed ID: 16868484
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide: is a new oral agent in treatment of acute pancreatitis?
Kutluana U; Oruc N; Nart D; Kaptanoglu B; Yonetci N; Ozutemiz O
Pancreas; 2010 Mar; 39(2):237-42. PubMed ID: 19770782
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis.
de Campos T; Deree J; Martins JO; Loomis WH; Shenvi E; Putnam JG; Coimbra R
Pancreas; 2008 Jul; 37(1):42-9. PubMed ID: 18580443
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs.
Sener G; Sehirli AO; Gedik N; Dülger GA
Burns; 2007 Aug; 33(5):587-93. PubMed ID: 17467912
[TBL] [Abstract][Full Text] [Related]
14. PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
Ivashchenko CY; Duan SZ; Usher MG; Mortensen RM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G319-26. PubMed ID: 17463185
[TBL] [Abstract][Full Text] [Related]
15. Taurocholate-induced pancreatitis: a model of severe necrotizing pancreatitis in mice.
Wittel UA; Wiech T; Chakraborty S; Boss B; Lauch R; Batra SK; Hopt UT
Pancreas; 2008 Mar; 36(2):e9-21. PubMed ID: 18376298
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis.
Xu P; Zhou XJ; Chen LQ; Chen J; Xie Y; Lv LH; Hou XH
World J Gastroenterol; 2007 Apr; 13(13):1983-8. PubMed ID: 17461502
[TBL] [Abstract][Full Text] [Related]
17. Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.
Abe M; Takiguchi Y; Ichimaru S; Kaji S; Tsuchiya K; Wada K
Eur J Pharmacol; 2008 Jul; 589(1-3):215-9. PubMed ID: 18571644
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
[TBL] [Abstract][Full Text] [Related]
19. The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats.
Zhou M; Chen B; Sun H; Deng Z; Andersson R; Zhang Q
Scand J Gastroenterol; 2011 Feb; 46(2):211-9. PubMed ID: 20950211
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of poly(ADP-ribose) polymerase attenuates acute kidney injury in sodium taurocholate-induced acute pancreatitis in rats.
Yu J; Deng W; Wang W; Ding Y; Jin H; Chen C; Chen X; Xiong X; Xu S
Pancreas; 2012 Nov; 41(8):1299-305. PubMed ID: 22750969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
